摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N-diisopropyl-N'-propyl-urea | 447429-10-9

中文名称
——
中文别名
——
英文名称
N,N-diisopropyl-N'-propyl-urea
英文别名
N,N-Diisopropyl-N'-propyl-harnstoff;1,1-Di(propan-2-yl)-3-propylurea
<i>N</i>,<i>N</i>-diisopropyl-<i>N</i>'-propyl-urea化学式
CAS
447429-10-9
化学式
C10H22N2O
mdl
MFCD02336804
分子量
186.297
InChiKey
AFQYKDDWBUDJMM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    参考文献:
    名称:
    On the Thermal Dissociation of Organic Compounds. VIII. The Effects of the Substituents on the Thermal Dissociation of Tri-substituted Ureas
    摘要:
    三取代脲在脂肪酸和醇中的热解离速率常数已被测定。结果显示,三取代脲的解离速度快于1,3-二取代脲。在三取代脲中,醇中的解离速率快于脂肪酸,而1,3-二取代脲则恰恰相反。不是通过加成反应形成的四取代脲在与三取代脲的相同条件下不发生反应。否定了涉及一个溶剂分子直接攻击脲的脲解离的双分子机制。
    DOI:
    10.1246/bcsj.29.51
  • 作为产物:
    参考文献:
    名称:
    On the Thermal Dissociation of Organic Compounds. VIII. The Effects of the Substituents on the Thermal Dissociation of Tri-substituted Ureas
    摘要:
    三取代脲在脂肪酸和醇中的热解离速率常数已被测定。结果显示,三取代脲的解离速度快于1,3-二取代脲。在三取代脲中,醇中的解离速率快于脂肪酸,而1,3-二取代脲则恰恰相反。不是通过加成反应形成的四取代脲在与三取代脲的相同条件下不发生反应。否定了涉及一个溶剂分子直接攻击脲的脲解离的双分子机制。
    DOI:
    10.1246/bcsj.29.51
点击查看最新优质反应信息

文献信息

  • Inhibitors of VEGF receptor and HGF receptor signaling
    申请人:Saavedra Mario Oscar
    公开号:US20070004675A1
    公开(公告)日:2007-01-04
    The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions
    该发明涉及抑制VEGF受体信号和HGF受体信号。该发明提供了抑制VEGF受体信号和HGF受体信号的化合物和方法。该发明还提供了治疗细胞增殖性疾病和病况的组合物和方法。
  • Inhibitors of protein tyrosine kinase activity
    申请人:Raeppel Stephane
    公开号:US20080004273A1
    公开(公告)日:2008-01-03
    This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling and HGF receptor signaling. More particularly, the invention relates to compounds, compositions and methods for the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
    这项发明涉及抑制蛋白酪氨酸激酶活性的化合物。具体而言,该发明涉及抑制生长因子受体蛋白酪氨酸激酶活性的化合物,导致受体信号传导的抑制,例如抑制VEGF受体信号传导和HGF受体信号传导。更具体地,该发明涉及用于抑制VEGF受体信号传导和HGF受体信号传导的化合物、组合物和方法。该发明还提供了用于治疗细胞增殖性疾病和病况的组合物和方法。
  • INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY
    申请人:Saavedra Mario Oscar
    公开号:US20080064718A1
    公开(公告)日:2008-03-13
    This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling and HGF receptor signaling. More particularly, the invention relates to compounds, compositions and methods for the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
    本发明涉及抑制蛋白酪氨酸激酶活性的化合物。特别是,本发明涉及抑制生长因子受体蛋白酪氨酸激酶活性的化合物,从而抑制受体信号传导,例如抑制VEGF受体信号和HGF受体信号的传导。更具体地,本发明涉及用于抑制VEGF受体信号和HGF受体信号的化合物、组合物和方法。本发明还提供了用于治疗细胞增殖性疾病和病状的组合物和方法。
  • KINASE INHIBITORS AND USES THEREOF
    申请人:Raeppel Stephane
    公开号:US20080255155A1
    公开(公告)日:2008-10-16
    This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds, compositions and methods for the inhibition of kinase activity. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions.
    本发明涉及抑制蛋白酪氨酸激酶活性的化合物。具体而言,本发明涉及抑制激酶活性的化合物、组合物和方法。本发明还提供用于治疗细胞增殖性疾病和病症的化合物、组合物和方法。
  • INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING
    申请人:Saavedra Oscar Mario
    公开号:US20120083482A1
    公开(公告)日:2012-04-05
    The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds of general formula (A) wherein A 1 is sulfur, A 3 is CH, A 2 is CH, D is heterocycle, Z is oxygen, SO 0-2 or NR, Ar is phenyl and G is not a ring, and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
    本发明涉及抑制VEGF受体信号和HGF受体信号的技术。本发明提供了通式(A)的化合物,其中A1为,A3为CH,A2为CH,D为杂环,Z为氧,SO0-2或NR,Ar为苯基,G不是环,并提供了抑制VEGF受体信号和HGF受体信号的方法。本发明还提供了治疗细胞增殖性疾病和病情的组合物和方法。
查看更多